Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...
“For many years, the standard of care for ASHL was based on the RATHL trial, where newly diagnosed patients were given two cycles of ABVD [doxorubicin, bleomycin, vinblastine, and dacarbazine] and ...
Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.
Jinx's devastated owner told Newsweek: "It’s so unfair and hurts so badly that I got robbed of many years with her." ...
Great Pet Care on MSN
IMHA in dogs
Although the exact incidence of IMHA in dogs is unknown, it’s considered one of the most common autoimmune conditions faced ...
The waveLINE-003 trial demonstrates the efficacy of zilovertamab vedotin combined with standard therapy, with manageable safety profiles in difficult-to-treat DLBCL patients. ADCs provide logistical ...
The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...
Cushing Syndrome is a relatively uncommon hormonal disorder that arises as a consequence of chronically elevated levels of ...
The injuries continue to stack up for former All-Star pitcher John Means. MLB Trade Rumors covers the Achilles tear he ...
Irvine: Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...
Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT FASPRO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback